Husband with mesothelioma | Wife with mesothelioma | |||
Cases | SIR (95% CI) | Cases | SIR (95% CI) | |
Mesothelioma | 1 | 2.12 (0.00–12.18) | 1 | 2.31 (0.00–13.26) |
Upper aerodigestive tract | 3 | 0.45 (0.09–1.34) | 1 | 0.29 (0.00–1.66) |
Oesophagus | 1 | 0.42 (0.00–2.39) | 2 | 1.56 (0.15–5.73) |
Stomach | 13 | 0.96 (0.51–1.65) | 11 | 2.08 (1.03–3.73)# |
Colon | 45 | 1.03 (0.75–1.37) | 8 | 0.99 (0.42–1.96) |
Rectum | 19 | 0.96 (0.58–1.50) | 6 | 1.11 (0.40–2.44) |
Liver | 18 | 1.19 (0.70–1.88) | 1 | 0.37 (0.00–2.11) |
Pancreas | 19 | 1.34 (0.81–2.10) | 3 | 0.96 (0.18–2.83) |
Lung | 35 | 1.13 (0.79–1.57) | 11 | 0.98 (0.48–1.75) |
Breast | 177 | 1.17 (1.01–1.36)# | 0 | |
Cervix | 14 | 0.74 (0.41–1.25) | 0 | |
Endometrium | 32 | 0.93 (0.63–1.31) | 0 | |
Ovary | 30 | 1.13 (0.76–1.62) | 0 | |
Prostate | 0 | 34 | 0.99 (0.69–1.39) | |
Kidney | 14 | 1.06 (0.58–1.79) | 8 | 2.11 (0.90–4.18) |
Urinary bladder | 16 | 1.23 (0.70–2.00) | 14 | 1.69 (0.92–2.84) |
Melanoma | 25 | 1.28 (0.83–1.89) | 1 | 0.30 (0.00–1.71) |
Skin, squamous cell | 32 | 1.47 (1.00–2.07)# | 5 | 0.91 (0.29–2.14) |
Nervous system | 22 | 1.29 (0.80–1.95) | 1 | 0.37 (0.00–2.11) |
Endocrine glands | 19 | 1.45 (0.87–2.26) | 2 | 1.90 (0.18–6.98) |
Connective tissue | 3 | 0.93 (0.17–2.74) | 0 | |
Non-Hodgkin lymphoma | 15 | 0.75 (0.42–1.24) | 7 | 1.42 (0.56–2.95) |
Myeloma | 9 | 1.27 (0.58–2.42) | 2 | 1.16 (0.11–4.26) |
Leukaemia | 6 | 0.64 (0.23–1.40) | 1 | 0.50 (0.00–2.87) |
Cancer of unknown primary | 21 | 1.02 (0.63–1.57) | 5 | 1.55 (0.49–3.65) |
All | 603 | 1.08 (1.00–1.18)# | 124 | 1.07 (0.89–1.28) |
Data are presented as n, unless otherwise indicated. SIR: standardised incidence ratio. #: p<0.05.